These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38093149)

  • 1. Early transition to avacopan from glucocorticoids applied during induction therapy for microscopic polyangiitis with rapidly progressive glomerulonephritis.
    Miyake H; Tanabe K; Yamaji S; Kihara T
    CEN Case Rep; 2024 Aug; 13(4):277-283. PubMed ID: 38093149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avacopan's potential to decrease MPO-ANCA titres concurrent with ameliorated activity in ANCA-associated vasculitis.
    Taniguchi T; Hiwa R; Shoji M; Yamaguchi E; Shirakashi M; Onizawa H; Tsuji H; Kitagori K; Nakashima R; Akizuki S; Onishi A; Yoshifuji H; Tanaka M; Morinobu A
    Mod Rheumatol Case Rep; 2024 Jul; 8(2):314-317. PubMed ID: 38564324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain.
    Macía M; Díaz-Encarnación M; Solans-Laqué R; Mallol EP; Castells AG; Escribano C; de Arellano AR
    Expert Rev Pharmacoecon Outcomes Res; 2024 Feb; 24(2):227-235. PubMed ID: 38126738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan.
    Alvarez L; Kambham N; Su R
    J Nephrol; 2023 Nov; 36(8):2365-2370. PubMed ID: 37036661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological and clinical profiles of avacopan (TAVNEOS
    Maruyama Y; Yoshida T; Maruyama I
    Nihon Yakurigaku Zasshi; 2023 Sep; 158(5):399-407. PubMed ID: 37460300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial.
    Geetha D; Dua A; Yue H; Springer J; Salvarani C; Jayne D; Merkel P;
    Ann Rheum Dis; 2024 Jan; 83(2):223-232. PubMed ID: 37979959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avacopan for the Treatment of ANCA-Associated Vasculitis.
    Jayne DRW; Merkel PA; Schall TJ; Bekker P;
    N Engl J Med; 2021 Feb; 384(7):599-609. PubMed ID: 33596356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.
    Kant S; Habbach A; Gapud EJ; Manno RL; Gattu R; Seo P; Geetha D
    Am J Nephrol; 2019; 50(5):386-391. PubMed ID: 31593967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Harigai M; Takada H
    Mod Rheumatol; 2022 Apr; 32(3):475-483. PubMed ID: 34984461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avacopan in the treatment of ANCA-associated vasculitis.
    Tesar V; Hruskova Z
    Expert Opin Investig Drugs; 2018 May; 27(5):491-496. PubMed ID: 29718732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Therapies for ANCA-associated Vasculitis.
    Monti S; Brandolino F; Milanesi A; Xoxi B; Delvino P; Montecucco C
    Curr Rheumatol Rep; 2021 Apr; 23(6):38. PubMed ID: 33909172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates in ANCA-associated vasculitis.
    Ross C; Makhzoum JP; Pagnoux C
    Eur J Rheumatol; 2022 Jul; 9(3):153-166. PubMed ID: 35156630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.
    Hellmich B; Sanchez-Alamo B; Schirmer JH; Berti A; Blockmans D; Cid MC; Holle JU; Hollinger N; Karadag O; Kronbichler A; Little MA; Luqmani RA; Mahr A; Merkel PA; Mohammad AJ; Monti S; Mukhtyar CB; Musial J; Price-Kuehne F; Segelmark M; Teng YKO; Terrier B; Tomasson G; Vaglio A; Vassilopoulos D; Verhoeven P; Jayne D
    Ann Rheum Dis; 2024 Jan; 83(1):30-47. PubMed ID: 36927642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Update on treatment of ANCA-associated vasculitis: Granulomatosis with polyangiitis and Microscopic Polyangiitis].
    Holle JU; Hellmich B; Moosig F
    Z Rheumatol; 2022 May; 81(4):280-285. PubMed ID: 35061059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How the Availability of Anti-C5a Agents Could Change the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Roccatello D; Fenoglio R; Oddone V; Sciascia S
    Kidney Blood Press Res; 2022; 47(8):506-513. PubMed ID: 35665698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.
    Jayne DRW; Bruchfeld AN; Harper L; Schaier M; Venning MC; Hamilton P; Burst V; Grundmann F; Jadoul M; Szombati I; Tesař V; Segelmark M; Potarca A; Schall TJ; Bekker P;
    J Am Soc Nephrol; 2017 Sep; 28(9):2756-2767. PubMed ID: 28400446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab in remission induction and maintenance therapy for microscopic polyangiitis associated with gastric cancer: A case report.
    Aritomi T; Nawata M; Nawata A; Himeno Y; Saito K; Tanaka Y
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):239-242. PubMed ID: 34904668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.